AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Haese, A Graefen, M Steuber, T Becker, C Pettersson, K Piironen, T Noldus, J Huland, H Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, PROSTATE, 49(2), 2001, pp. 101-109

Authors: Nurmikko, P Pettersson, K Piironen, T Hugosson, J Lilja, H
Citation: P. Nurmikko et al., Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys(145)-Lys(146), CLIN CHEM, 47(8), 2001, pp. 1415-1423

Authors: Piironen, T Nurmi, M Irjala, K Heinonen, O Lilja, H Lovgren, T Pettersson, K
Citation: T. Piironen et al., Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: Implications for point-of-care testing, CLIN CHEM, 47(4), 2001, pp. 703-711

Authors: Siivola, P Pettersson, K Piironen, T Lovgren, T Lilja, H Bjartell, A
Citation: P. Siivola et al., Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections, UROLOGY, 56(4), 2000, pp. 682-688

Authors: Becker, C Piironen, T Pettersson, K Hugosson, J Lilja, H
Citation: C. Becker et al., Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater, UROLOGY, 55(5), 2000, pp. 694-699

Authors: Recker, F Kwiatkowski, MK Piironen, T Pettersson, K Huber, A Lummen, G Tscholl, R
Citation: F. Recker et al., Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen, UROLOGY, 55(4), 2000, pp. 481-485

Authors: Becker, C Piironen, T Pettersson, K Bjork, T Wojno, KJ Oesterling, JE Lilja, H
Citation: C. Becker et al., Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (hK2) in serum, J UROL, 163(1), 2000, pp. 311-316

Authors: Becker, C Piironen, T Kiviniemi, J Lilja, H Pettersson, K
Citation: C. Becker et al., Sensitive and specific immunodetection of human glandular kallikrein 2 in serum, CLIN CHEM, 46(2), 2000, pp. 198-206

Authors: Nurmikko, P Vaisanen, V Piironen, T Lindgren, S Lilja, H Pettersson, K
Citation: P. Nurmikko et al., Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA, CLIN CHEM, 46(10), 2000, pp. 1610-1618

Authors: Vaisanen, V Lovgren, L Hellman, J Piironen, T Lilja, H Pettersson, K
Citation: V. Vaisanen et al., Characterization and processing of prostate specific antigen (hk3) and human glandular kallikrein (hK2) secreted by LNCaP cells, PROSTATE C, 2(2), 1999, pp. 91-97

Authors: Stenman, UH Paus, E Allard, WJ Andersson, I Andres, C Barnett, TR Becker, C Belenky, A Bellanger, L Pellegrino, CM Bormer, OP Davis, G Dowell, B Grauer, LS Jette, DC Karlsson, B Kreutz, FT van der Kwast, TM Lauren, L Leinimaa, M Leinonen, J Lilja, H Linton, HJ Nap, M Nilsson, O Ng, PC Nustad, K Peter, A Pettersson, K Piironen, T Rapp, J Rittenhouse, HG Rye, PD Seguin, P Slota, J Sokoloff, RL Suresh, MR Very, DL Wang, TJ Wigheden, I Wolfert, RL Yeung, KK Zhang, WM Zhou, Z Hilgers, J
Citation: Uh. Stenman et al., Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 1-12

Authors: Leinonen, J Leinimaa, M Zhang, WM Piironen, T Pettersson, K Lilja, H Dowell, B Stenman, UH
Citation: J. Leinonen et al., Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2, TUMOR BIOL, 20, 1999, pp. 35-37

Authors: Lilja, H Haese, A Bjork, T Friedrich, MG Piironen, T Pettersson, K Huland, E Huland, H
Citation: H. Lilja et al., Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy, J UROL, 162(6), 1999, pp. 2029-2034

Authors: Recker, F Kwiatkowski, WK Piironen, T Pettersson, K Lummen, G Wernli, M Wiefelsputz, J Graber, SF Goepel, M Huber, A Tscholl, R
Citation: F. Recker et al., The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma, CANCER, 83(12), 1998, pp. 2540-2547
Risultati: 1-14 |